Startups
2003
SOM INNOVATION BIOTECH SAHarnessing the power of Artificial Intelligence to unlock further potential of known drugs for orphan diseases
We leverage the power of Artificial Intelligence to repurpose drugs for orphan diseases
We leverage the power of Artificial Intelligence to repurpose drugs for orphan diseases
Address
Carrer de Baldiri Reixac 4, 08028 Barcelona, Spain
Finance Data
CERCA ownership
Lleida, Spain
2004
Institut de Recerca Biomèdica de Lleida (IRBLLEIDA)
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
OUR APPROACH
Leveraging the power of Artificial Intelligence
Focused on orphan diseases
Repurposing drugs for new therapeutic indications
Leveraging the power of Artificial Intelligence
Focused on orphan diseases
Repurposing drugs for new therapeutic indications
Product description
Pipeline:
SOM3355: Chorea movements associated with Huntington’s disease
SOM0226: TTR amyloidosis
SOM1311: Phenylketonuria
SOM3366: Tardive Dyskinesia
SOM0061: COVID-19
SOM0777: Glioblastoma
SOM3355: Chorea movements associated with Huntington’s disease
SOM0226: TTR amyloidosis
SOM1311: Phenylketonuria
SOM3366: Tardive Dyskinesia
SOM0061: COVID-19
SOM0777: Glioblastoma